Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. China
  4. Shenzhen Stock Exchange
  5. Shijiazhuang Yiling Pharmaceutical Co., Ltd.
  6. Summary
    002603   CNE1000015S0

SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.

(002603)
  Report
 SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Shenzhen Stock Exchange
11/29/2021 11/30/2021 12/01/2021 12/02/2021 12/03/2021 Date
16.79 17.15 16.8 16.61 16.61 Last
29398230 27846540 16113230 12291920 8659136 Volume
+2.94% +2.14% -2.04% -1.13% 0.00% Change
Estimated financial data (e)
Sales 2021 11 298 M 1 772 M 1 772 M
Net income 2021 1 675 M 263 M 263 M
Net Debt 2021 - - -
P/E ratio 2021 16,6x
Yield 2021 2,30%
Sales 2022 13 292 M 2 085 M 2 085 M
Net income 2022 2 062 M 323 M 323 M
Net Debt 2022 - - -
P/E ratio 2022 13,5x
Yield 2022 0,67%
Capitalization 27 750 M 4 352 M 4 352 M
Capi. / Sales 2021 2,46x
Capi. / Sales 2022 2,09x
Nbr of Employees 16 912
Free-Float 40,9%
More Financials
Company
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD is a China-based company, principally engaged in the research and development, manufacture and distribution of pharmaceuticals. The Company mainly provides cardiovascular and cerebrovascular drugs and anti-cold drugs. The Company also provides food and beverage products. The Company distributes its products within domestic market and to overseas markets. 
Sector
Pharmaceuticals
Calendar
04/28Earnings Release
More about the company
Ratings of Shijiazhuang Yiling Pharmaceutical Co., Ltd.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C
More Ratings
All news about SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.
10/08Shijiazhuang Yiling Pharmaceutical Co., Ltd. announced a financing transaction
CI
08/25Shijiazhuang Yiling Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year..
CI
07/05HS Bio Sdn. Bhd. Enters into MOU with Shijiazhuang Yiling Pharmaceutical Co., Ltd
CI
07/01Shijiazhuang Yiling Pharmaceutical Co., Ltd. Announces 2020 Final Distribution Plan to ..
CI
05/11Shijiazhuang Yiling Pharmaceutical Co., Ltd. Approves Dividend for the Year 2020
CI
04/28Shijiazhuang Yiling Pharmaceutical Co., Ltd. Reports Earnings Results for the First Qua..
CI
04/09Shijiazhuang Yiling Pharmaceutical Co., Ltd. Proposes Final Cash Dividend for 2020
CI
04/08Shijiazhuang Yiling Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year..
CI
03/16SHIJIAZHUANG YILING PHARMACEUTICAL : Yiling Pharmaceutical Wins Nod to Market COVID-19 Her..
MT
03/16Yiling Pharmaceutical Receives Approval for Lianhua Qingwen Capsules from The Pharmacy ..
CI
01/06SHIJIAZHUANG YILING PHARMACEUTICAL : Yiling Pharma expects to double its YoY net profit in..
AQ
01/06Yiling Pharmaceutical Provides Earnings Guidance for 2020
CI
2020SHIJIAZHUANG YILING PHARMACEUTICAL : Gets Philippines' Nod for Traditional Chinese Covid-1..
MT
2020Yiling Pharmaceutical Announces Lianhua Qingwen Capsules Obtained Approval in the Phili..
CI
2020Yiling Pharmaceutical Receives Certificate of Registration for Dietary Supplements
CI
More news
News in other languages on SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.
07/01Shijiazhuang Yiling Pharmaceutical Co., Ltd. annonce la mise en œuvre du plan de distri..
More news
Chart SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.
Duration : Period :
Shijiazhuang Yiling Pharmaceutical Co., Ltd. Technical Analysis Chart | 002603 | CNE1000015S0 | MarketScreener
Technical analysis trends SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.
Short TermMid-TermLong Term
TrendsBullishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 3
Last Close Price 16,61 CNY
Average target price 24,64 CNY
Spread / Average Target 48,4%
EPS Revisions
Managers and Directors
Xiang Jun Wu General Manager & Director
Chen Guang Li Chief Financial Officer & Director
Yi Ling Wu Chairman
Xue Dong Gao Chairman-Supervisory Board
Zhen Wang Independent Director